Clinilabs Selected for a Phase I/II Study of HIV Vaccine
Clinilabs announced that they have been selected to conduct a Phase I/II clinical research study of an investigational vaccine for HIV.
According to Dr. Howard Greenberg, Senior Medical Director of Clinilabs, "Conducting early phase clinical trials with a novel therapeutic in a new patient population is a major advance in Clinilabs’ progression as a CRU.”
Greenberg also notes that conducting vaccine studies and expanding enrollment of specialty patient populations are two key strategic directions Clinilabs is pursuing to capitalize on its position as a global CRO that operates a CRU in New York City, a hub of academic medical centers and home to a diverse population of more than 19 million potential research subjects.
Enrollment for this study is expected to begin later this month.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
